NICE rejects Zytiga as prostate cancer treatment before chemotherapy
In its final draft guidance, NICE has not recommended abiraterone for prostate cancer in people who received hormone therapy (androgen deprivation) but whose disease has spread, who have few symptoms and when chemotherapy would not yet have been given. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 15, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Oncology abiraterone janssen Latest News nice prostate cancer Zytiga Source Type: news
Gilead’s new hepatitis C treatment Sovaldi®
Sovaldi (sofosbuvir) should be made available, as part of a combination treatment regimen, to treat the majority of adult patients with chronic hepatitis C in England and Wales. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 15, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Hepatic disorders chronic hepatitis C gilead hcv Latest News National Institute for Health and Care Excellence nice Sofosbuvir Sovaldi Source Type: news
Fluzone® High-Dose vaccine data
Sanofi Pasteur has announced Fluzone High-Dose (Influenza Vaccine) was more efficacious in preventing influenza in adults 65 years of age and older compared with standard-dose Fluzone vaccine. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 14, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Infectious Disease Fluzone® High-Dose Vaccine Latest News sanofi pasteur Source Type: news
Ebola victims include pharmacy professionals
Community pharmacy professionals are among the Ebola fatalities of health care workers in Sierra Leone, although reported numbers vary. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 14, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News Healthcare worker safety Ebola fip international pharmaceutical federation Latest News pharmacists West Africa Source Type: news
RPS calls for expansion of the New Medicine Service
Following a positive independent academic evaluation of the New Medicine Service, Dr David Branford, Chair of the Royal Pharmaceutical Society English Board, has called for inclusion of a wider cohort of patients to allow more people with newly diagnosed long-term conditions to benefit. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 14, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News David Branford Latest News New Medicine Service royal pharmaceutical society RPS Source Type: news
Forthcoming UKCPA events
The UKCPA has announced a number of events that are due to take place in September and October 2014, all of which have been endorsed by the RPS. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 14, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News events Latest News ukcpa Source Type: news
EYLEA® receives third licence in Europe
EYLEA is an established treatment for other eye conditions that could now offer patients with DMO significant visual benefits, from start of treatment, without the need for strict monthly hospital visits (after an initial five monthly loading doses); potentially reducing the burden of treatment for patients already having to manage their diabetes.(2,3) (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 12, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Ophthalmology Latest News Source Type: news
Data demonstrates 'efficacy and tolerability' of IDegLira
Diabetes Care has published phase IIIa findings that demonstrate a significantly greater glucose-lowering effect with IDegLira compared with insulin degludec. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 11, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Diabetes IDegLira insulin degludec/liraglutide Latest News type 2 diabetes Xultophy Source Type: news
EAHP China tour develops important relationship
The European Association of Hospital Pharmacists (EAHP) has recently completed a tour of China to promote practice developments in European hospital pharmacy and develop its relations with organisations in China. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 11, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Association News china eahp European Association of Hospital Pharmacists Latest News Source Type: news
Management of facial flushing in rosacea
Mirvaso® is the first topical a2-receptor agonist licensed for treating persistent facial flushing in rosacea, which can have a huge psychological impact on sufferers (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 8, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
Advanced therapy medicinal products
This article summarises what advanced therapy medicinal products (ATMPs) are, how their regulation is performed and the associated challenges, and discusses some of ATMPs registered in Europe and their therapeutic uses (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 8, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
Treating hospital-acquired pneumonia
This article reviews telavancin’s pharmacological characteristics as evidenced by clinical trials and studies, to provide a detailed picture of its use in the management of hospital-acquired pneumonia (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 8, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
Improving medicines reconciliation on admission
In the first of two articles provided by North Bristol NHS Trust, the focus will be on the background of medicines reconciliation and our work at North Bristol to first implement and then improve on medicines reconciliation on admission (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 8, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
e-Prescribing and robotic dispensing: part III
This latest article in this series focuses on the effect electronic prescribing and robotic dispensing have at ward level, and their combined influence on pharmacy professionalism (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 8, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
Optimising adherence and QoL in metastatic NSCLC
Epidermal growth factor receptor tyrosine kinase inhibitors are widely used in the management of metastatic non-small cell lung cancer. Adverse events, their impact on quality of life and treatment adherence with these oral drugs are discussed (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 8, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: Featured Articles Source Type: news
